|
|
|
|
|
Last Trade
|
Last Trade:
$1.29
|
Change:
0.09 (7.50%)
|
Trade Time:
02:40 PM EST
|
Market Cap:
$63.19M
|
|
|
|
|
|
|
Description of Business
|
|
In this Annual Report, the terms, "we," "us," "our" or the "Company" refer to
Emmaus Life Sciences, Inc., and its subsidiaries.
As reported in more detail in our Current Report on Form 8-K filed with the SEC
on July 22, 2019, as amended by our Form 8-K/A filed on August 14, 2019, on July
17, 2019, we completed our merger transaction with EMI Holding, Inc., formerly
known as Emmaus Life Sciences, Inc. ("EMI"), in accordance with the terms of the
Agreement and Plan of Merger and Reorganization, dated as of January 4, 2019,
among us, Athena Merger Subsidiary, Inc., and EMI, as amended by Amendment No. 1
thereto, dated as of May 10, 2019, which we refer to as the merger agreement.
Pursuant to the merger agreement, Athena Merger Subsidiary, Inc. merged into
EMI, with EMI surviving as our wholly owned subsidiary. On July 17, 2019,
immediately after completion of the merger, we changed our name to "Emmaus Life
Sciences, Inc.
|
|
|
|